CLDX
Celldex Therapeutics (CLDX) Investor Questions
Review Celldex Therapeutics (CLDX) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Celldex Therapeutics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 50
- Annual revenue
- $1.54M
- Annual net income
- $-258.76M
- Annual free cash flow
- $-213.66M
Celldex Therapeutics (CLDX) Investor Questions research
Celldex Therapeutics trades under the ticker CLDX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review CLDX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.